Pharsight

SHIRE HUMAN GENETICS THERAPIES INC PATENTS FACING OPPOSITIONS

Top patents of SHIRE HUMAN GENETICS THERAPIES INC facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3626258B1 04 Aug, 2021 Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase Jun, 2031 1
EP3103469B1 09 Dec, 2020 Cns Delivery Of Therapeutic Agents Jun, 2031 1